[1-[2-(4-tert-butylphenyl)-6-phenyl-4-(trideuteriomethyl)phenyl]-3-[3-[[6-(3,4,5,6-tetradeuterio-9-phenyl-8,10-diaza-9-boratetracyclo[6.6.1.02,7.011,15]pentadeca-1(15),2,4,6,11,13-hexaen-10-yl)-2-pyridinyl]oxy]phenyl]benzimidazol-2-ylidene]platinum
C59H46BN5OPt — CID 177090374
Data last refreshed: (MolForge compound catalog, from PubChem)
About [1-[2-(4-tert-butylphenyl)-6-phenyl-4-(trideuteriomethyl)phenyl]-3-[3-[[6-(3,4,5,6-tetradeuterio-9-phenyl-8,10-diaza-9-boratetracyclo[6.6.1.02,7.011,15]pentadeca-1(15),2,4,6,11,13-hexaen-10-yl)-2-pyridinyl]oxy]phenyl]benzimidazol-2-ylidene]platinum
[1-[2-(4-tert-butylphenyl)-6-phenyl-4-(trideuteriomethyl)phenyl]-3-[3-[[6-(3,4,5,6-tetradeuterio-9-phenyl-8,10-diaza-9-boratetracyclo[6.6.1.02,7.011,15]pentadeca-1(15),2,4,6,11,13-hexaen-10-yl)-2-pyridinyl]oxy]phenyl]benzimidazol-2-ylidene]platinum (PubChem CID 177090374) has the molecular formula C59H46BN5OPt and a molecular weight of 1053.98 g/mol. Its IUPAC name is [1-[2-(4-tert-butylphenyl)-6-phenyl-4-(trideuteriomethyl)phenyl]-3-[3-[[6-(3,4,5,6-tetradeuterio-9-phenyl-8,10-diaza-9-boratetracyclo[6.6.1.02,7.011,15]pentadeca-1(15),2,4,6,11,13-hexaen-10-yl)-2-pyridinyl]oxy]phenyl]benzimidazol-2-ylidene]platinum.
Molecular Properties
| Compound Name | [1-[2-(4-tert-butylphenyl)-6-phenyl-4-(trideuteriomethyl)phenyl]-3-[3-[[6-(3,4,5,6-tetradeuterio-9-phenyl-8,10-diaza-9-boratetracyclo[6.6.1.02,7.011,15]pentadeca-1(15),2,4,6,11,13-hexaen-10-yl)-2-pyridinyl]oxy]phenyl]benzimidazol-2-ylidene]platinum |
|---|---|
| PubChem CID | 177090374 |
| Molecular Formula | C59H46BN5OPt |
| Molecular Weight | 1053.98 g/mol |
| Exact Mass | 1053.39 |
| IUPAC Name | [1-[2-(4-tert-butylphenyl)-6-phenyl-4-(trideuteriomethyl)phenyl]-3-[3-[[6-(3,4,5,6-tetradeuterio-9-phenyl-8,10-diaza-9-boratetracyclo[6.6.1.02,7.011,15]pentadeca-1(15),2,4,6,11,13-hexaen-10-yl)-2-pyridinyl]oxy]phenyl]benzimidazol-2-ylidene]platinum |
| SMILES | [2H]c1c([2H])c([2H])c2c(c1[2H])c1cccc3c1n2B(c1ccccc1)N3c1cccc(Oc2cccc(-n3c(=[Pt])n(-c4c(-c5ccccc5)cc(C([2H])([2H])[2H])cc4-c4ccc(C(C)(C)C)cc4)c4ccccc43)c2)n1 |
| InChI | InChI=1S/C59H46BN5O.Pt/c1-40-36-49(41-18-7-5-8-19-41)57(50(37-40)42-32-34-43(35-33-42)59(2,3)4)63-39-62(52-27-13-14-28-53(52)63)45-22-15-23-46(38-45)66-56-31-17-30-55(61-56)64-54-29-16-25-48-47-24-11-12-26-51(47)65(58(48)54)60(64)44-20-9-6-10-21-44;/h5-38H,1-4H3;/i1D3,11D,12D,24D,26D; |
| InChIKey | ILOSHMXYKAMTBG-MYYKBQBVSA-N |
| XLogP | 14.13 |
| TPSA | 40.15 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 67 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1053.98 |
| LogP ≤ 5 | 14.13 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177090374 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.